In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Findings Demonstrate Bi-Dose Nasal Spray Device Delivered Epinephrine Levels with a Release Profile Comparable to or Greater than Epinephrine Auto-Injector
ZyVersa is well positioned in the rapidly emerging inflammasome space with a highly differentiated inflammasome inhibitor (IC 100), and in kidney disease with a first-in-class phase 2a-ready cholesterol efflux mediator (VAR 200) for treatment of orphan renal disease FSGS and other kidney diseases (Alport Syndrome, DKD)
Technology leaders, change makers and visionaries from across the global networking & edge communities will gather virtually for this unique, one-of-a-kind executive event focusing on deployment progress, 2021 priorities, challenges and more.
